A 6-month-old male infant presents with poor weight gain, developmental delay, and recurrent infections. Urine dipstick shows a positive reducing substance that does NOT react with glucose oxidase. On examination, the child has a distinctive sweet or 'maple syrup' odour to the urine and sweat. Which investigation is most appropriate to confirm the suspected diagnosis?

Explanation

## Diagnosis: Maple Syrup Urine Disease (MSUD) ### Clinical Presentation The vignette describes classic MSUD: poor weight gain, developmental delay, recurrent infections, sweet or 'maple syrup' odour in urine and sweat, and a positive reducing substance on urine dipstick that is glucose oxidase-negative (indicating non-glucose reducing sugars — the branched-chain α-ketoacids). ### Investigation of Choice **Key Point:** Plasma branched-chain amino acid (BCAA) levels with calculation of the branched-chain amino acid ratio (Leucine:Isoleucine) is the gold standard confirmatory test for MSUD. ### Why Plasma BCAA Levels? 1. **Direct measurement of the metabolic defect:** - MSUD results from deficiency of branched-chain α-ketoacid dehydrogenase complex (BCKDC) - Accumulation of leucine, isoleucine, and valine (and their α-ketoacids) in plasma - Leucine is typically most elevated 2. **Diagnostic criteria:** - Plasma leucine >300 µmol/L (normal <150) - Plasma isoleucine >150 µmol/L (normal <100) - Elevated Leu:Ile ratio (normally ~1.5–2.0; in MSUD often >3–4) 3. **Specificity:** - Elevated BCAAs are pathognomonic for MSUD - Allows classification of severity (classic, intermediate, thiamine-responsive) ### Supporting Investigations | Investigation | Finding in MSUD | Role | |---|---|---| | **Plasma BCAA levels** | ↑ Leucine, isoleucine, valine | Gold standard confirmatory test | | **Urine organic acids (GC-MS)** | ↑ Branched-chain α-ketoacids | Supports diagnosis; shows metabolic pattern | | **Urine amino acids** | ↑ BCAAs | Secondary finding; less specific | | **Serum carnitine** | May be ↓ (secondary) | Not diagnostic; used for monitoring | **High-Yield:** The urine reducing substance that is glucose oxidase-negative is a key clue — it represents branched-chain α-ketoacids (α-ketoisocaproate, α-ketoisovalerate), which are reducing sugars but not glucose. **Clinical Pearl:** Early diagnosis via newborn screening (tandem MS detecting elevated BCAAs) and immediate dietary restriction of leucine, isoleucine, and valine can prevent neurological damage and intellectual disability. **Mnemonic: MSUD = BCAA Elevation** — **M**aple **S**yrup **U**rine **D**isease is confirmed by elevated **B**ranched-**C**hain **A**mino **A**cids in plasma.